<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pancreatitis Risk on What is a GLP-1 Patch? | Comprehensive Guide &amp; Insights</title>
		<link>https://5485.22887.cc/tags/pancreatitis-risk/</link>
		<description>Recent content in Pancreatitis Risk on What is a GLP-1 Patch? | Comprehensive Guide &amp; Insights</description>
		<generator>Hugo</generator>
		<language>en-US</language>
		
		
		
		
			<lastBuildDate>Sat, 18 Oct 2025 18:05:29 -0500</lastBuildDate>
		
			<atom:link href="https://5485.22887.cc/tags/pancreatitis-risk/index.xml" rel="self" type="application/rss+xml" />
			<item>
				<title>Are GLP-1s Safe: A Real-World Look at the Evidence and Risks</title>
				<link>https://5485.22887.cc/posts/are-glp-1s-safe-a-real-world-look-at-the-evidence-and-risks/</link>
				<pubDate>Sat, 18 Oct 2025 18:05:29 -0500</pubDate>
				<guid>https://5485.22887.cc/posts/are-glp-1s-safe-a-real-world-look-at-the-evidence-and-risks/</guid>
				<description>&lt;p&gt;Short answer: yes, GLP-1 receptor agonists are generally safe for most adults when prescribed appropriately, but they&amp;rsquo;re not risk-free. Think nausea, vomiting, and that &amp;ldquo;full&amp;rdquo; feeling that sometimes turns into full-blown stomach cramps. Rare but serious issues like pancreatitis and gallbladder problems do show up in trials. The FDA has approved these drugs for diabetes since 2005 and for obesity since 2014 (FDA, &lt;a href=&#34;https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-fda-warns-about-risks-bowel-obstruction-rarely-reported-use-glp-1&#34; rel=&#34;nofollow noopener&#34; target=&#34;_blank&#34;&gt;https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-fda-warns-about-risks-bowel-obstruction-rarely-reported-use-glp-1&lt;/a&gt; But &amp;ldquo;safe&amp;rdquo; depends heavily on you—your history, your dose, and whether you&amp;rsquo;re being monitored.&lt;/p&gt;</description>
			</item>
	</channel>
</rss>
